en
Scientific article
French

Actualités vaccinologiques suisses: nouveaux vaccins glycoconjugués contre pneumocoques et méningocoques

Published inRevue médicale suisse, vol. 7, no. 278, p. 154-158
Publication date2011
Abstract

Two new glycoconjugate vaccines protecting against invasive diseases caused by 13 pneumococcal serotypes or 4 meningococcal serogroups will soon be available in Switzerland. They offer real new perspectives for young children, and for high-risk group adults. As their development is recent, the data one may wish to have is not yet fully available for each age and disease categories. This article attempts to delineate the interest of these new glycoconjugate vaccines and their limits. The additional information (and the answers to numerous expected questions) will be distributed to the 4300 subscribers of InfoVac (www.infovac. ch), which just celebrated its 10th birthday.

Keywords
  • Humans
  • Meningococcal Infections/prevention & control
  • Meningococcal Vaccines/therapeutic use
  • Pneumococcal Infections/prevention & control
  • Pneumococcal Vaccines/therapeutic use
  • Vaccines, Conjugate
Citation (ISO format)
SIEGRIST, Claire-Anne. Actualités vaccinologiques suisses: nouveaux vaccins glycoconjugués contre pneumocoques et méningocoques. In: Revue médicale suisse, 2011, vol. 7, n° 278, p. 154–158.
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1660-9379
420views
1downloads

Technical informations

Creation12/19/2012 10:48:00 AM
First validation12/19/2012 10:48:00 AM
Update time03/14/2023 7:56:19 PM
Status update03/14/2023 7:56:19 PM
Last indexation01/16/2024 12:53:43 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack